Peter F. Lang
Director of Finance/CFO at OPTHEA LIMITED
Peter F. Lang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OPTHEA LIMITED | Director of Finance/CFO | 2023-10-26 | - |
Career history of Peter F. Lang
Former positions of Peter F. Lang
| Companies | Position | Start | End |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 2022-03-17 | 2022-11-20 |
| Ridge Advisory LLC | Corporate Officer/Principal | - | - |
Training of Peter F. Lang
| The University of Chicago Booth School of Business | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Australia | 2 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
| Ridge Advisory LLC | Commercial Services |
- Stock Market
- Insiders
- Peter F. Lang
- Experience
